SCHEMBL5280840

SCHEMBL5280840

CC(C)=N/N=c1\scc(-c2cccc(Cl)c2)n1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.40
DYRK3 O43781 1/20 0.36
CCNT1 O60563 1/20 0.36
CCNA2 P20248 1/20 0.36
CDK2 P24941 1/20 0.36
CDK9 P50750 1/20 0.36
CDK5 Q00535 1/20 0.36
DYRK1A Q13627 1/20 0.36
CDK5R1 Q15078 1/20 0.36
DYRK2 Q92630 1/20 0.36
DYRK1B Q9Y463 1/20 0.36
ABL1 P00519 1/20 0.36
ATP4A P20648 2/20 0.35
ATP4B P51164 2/20 0.35
KMT2A Q03164 1/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5280844 1.00 IDO1 (0.40) IDO1DYRK3CCNT1CCNA2CDK2
SCHEMBL5282035 0.85 RXFP1 (0.45) ABL1ATP4AATP4BNPC1RAB9A
SCHEMBL5282033 0.85 RXFP1 (0.45) ABL1ATP4AATP4BNPC1RAB9A
SCHEMBL5285390 0.84 ALDH1A1 (0.35) KMT2ARAB9AGAAMAPTMAPK1
SCHEMBL5285396 0.84 ALDH1A1 (0.35) KMT2ARAB9AGAAMAPTMAPK1
SCHEMBL5278421 0.83 MAPT (0.39) IDO1KMT2AGAAMAPTMAPK1
SCHEMBL5278424 0.83 MAPT (0.39) IDO1KMT2AGAAMAPTMAPK1
SCHEMBL5283771 0.83 SMN1; SMN2 (0.43) NPC1RAB9AGAAMAPTMAPK1
SCHEMBL5283764 0.83 SMN1; SMN2 (0.43) NPC1RAB9AGAAMAPTMAPK1
SCHEMBL4613816 0.81 IDO1 (0.43) IDO1DYRK3CCNT1CCNA2CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599178-B1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AG (DE) 2007-12-19 EP claimed
US-20060070190-A1 Means and method for dyeing keratin fibres KOYO SEIKO CO., LTD. (JP) 2006-04-06 US claimed
EP-1599178-B1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AG (DE) 2007-12-19 EP disclosed
US-7294151-B2 Means and method for dyeing keratin fibres WELLA AG (DE) 2007-11-13 US disclosed
US-20060070190-A1 Means and method for dyeing keratin fibres KOYO SEIKO CO., LTD. (JP) 2006-04-06 US disclosed
EP-1599178-A1 MEANS AND METHOD FOR DYEING KERATIN FIBRES Wella Aktiengesellschaft (DE) 2005-11-30 EP disclosed
WO-2004078151-A1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AKTIENGESELLSCHAFT (DE) 2004-09-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060070190-A1 Means and method for dyeing keratin fibres KRT18, KLK5, KIT IDO1 3955/4885DYRK3 1231/4885CCNT1 2957/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.